<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02336620</url>
  </required_header>
  <id_info>
    <org_study_id>RF_58015</org_study_id>
    <nct_id>NCT02336620</nct_id>
  </id_info>
  <brief_title>Balanced Salt Solution VS. Normal Saline Solution in Septic Shock</brief_title>
  <official_title>Balanced Salt Solution Versus Normal Saline Solution During Initial Resuscitation in Severe Sepsis or Septic Shock Children: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of this study is to determine the impact of balanced salt solution versus
      chloride rich solution on clinical outcomes in paediatric severe sepsis or septic shock
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The surviving sepsis campaign guideline recommended the isotonic crystalloids as the first
      choice of initial fluid resuscitation. The isotonic crystalloids are including chloride-rich
      solution (eg.NSS) and balanced salt solution. Retrospective study showed normal saline can
      induced hyperchloremic metabolic acidosis and acute kidney injury. However, no randomized
      controlled trial compare efficacy between the balanced salt solution and chloride rich
      solution.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">January 30, 2017</completion_date>
  <primary_completion_date type="Actual">January 30, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of hyperchloremic metabolic acidosis</measure>
    <time_frame>48 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>28 day and 90 day mortality rate</measure>
    <time_frame>28 days and 90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Shock, Septic</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Ringer Acetate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ringer acetate 10-20 ml/kg IV bolus when patient need fluid bolus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NSS 10-20 ml/kg IV bolus when patient need fluid bolus</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer acetate</intervention_name>
    <description>Ringer acetate 10-20 ml/kg IV bolus in 15-30 min,repeat bolus as needed by patient status</description>
    <arm_group_label>Ringer Acetate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>NSS 10-20 ml/kg IV bolus in 15-30 min,repeat bolus as needed by patient status</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>NSS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children younger than 18 year old who has severe sepsis or septic shock

          -  inform consent

        Exclusion Criteria:

          -  children who had shock from other aetiologies

          -  end stage disease or severe congenital anomaly

          -  refuse to inform consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nattachai Anantasit, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramathibodi Hospital, Bangkok</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatric,Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ramathibodi Hospital</investigator_affiliation>
    <investigator_full_name>Nattachai Anantasit</investigator_full_name>
    <investigator_title>Pediatric Department, Ramathibodi Hospital</investigator_title>
  </responsible_party>
  <keyword>Severe sepsis, Balanced Salt Solution, Normal Saline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

